WALLONIA-BIOMED — LIV — CER (Q4027005): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Created claim: summary (P836): Development of a research project in the field of molecular regulation of T lymphocyte differentiation for immunotherapy and vaccination., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
Development of a research project in the field of molecular regulation of T lymphocyte differentiation for immunotherapy and vaccination. (English) | |||||||||||||||
| Property / summary: Development of a research project in the field of molecular regulation of T lymphocyte differentiation for immunotherapy and vaccination. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Development of a research project in the field of molecular regulation of T lymphocyte differentiation for immunotherapy and vaccination. (English) / qualifier | |||||||||||||||
point in time: 17 January 2022
| |||||||||||||||
Revision as of 21:18, 17 January 2022
Project Q4027005 in Belgium
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | WALLONIA-BIOMED — LIV — CER |
Project Q4027005 in Belgium |
Statements
61,071.2 Euro
0 references
152,678.0 Euro
0 references
40.0 percent
0 references
15 May 2014
0 references
31 December 2023
0 references
CER-Groupe
0 references
50°11'10.64"N, 5°17'59.03"E
0 references
6900
0 references
Développement d'un projet de recherche dans le domaine de la régulation moléculaire de la différenciation des lymphocytes T pour l'immunothérapie et la vaccination. (French)
0 references
Development of a research project in the field of molecular regulation of T lymphocyte differentiation for immunotherapy and vaccination. (English)
17 January 2022
0 references
Identifiers
WAL-875
0 references